Better co-ordination, UDI key to improving EU medtech framework: UK ABHI
This article was originally published in SRA
An inquiry by the UK Parliament's Science & Technology Committee (STC) into patient safety entered a new stage on 13 June with an oral evidence session focusing on the regulation of medical implants1,2.
You may also be interested in...
Discussions on the shape of health care have moved from “reimagining” to the next stage: building and executing on the vision. That is the thrust of EY’s NextWave Report: New Horizons 2019. Additionally, for medtechs seeking business continuum, “duality” is now a preoccupying thought.
The idea that public corporations have obligations that extend beyond the fiduciary responsibility to shareholders will be the dominant measure of responsible business behavior in the coming decade. Uncertainty about the extent of these commitments – commonly referenced as the environmental, social and governance (ESG) agenda – has produced equally variable responses from companies in the health care business.